Global Animal Health Surgery Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Animal Health Surgery Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Animal health surgery drugs are defined as drugs administered to animals most preferably before a surgery, after the surgery, or during the surgical procedure, based on the type of surgery being performed on the animal
Animal Health Surgery Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Animal Health Surgery Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Orthopedic Surgery and Dental Surgery are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Animal Health Surgery Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Animal Health Surgery Drug key companies include Merck Animal Health (Merck & Co., Inc.), Boehringer Ingelheim International GmbH., Elanco Animal Health Incorporated, Virbac S.A., Biogenesis Bago SA, Piramal Group, Zoetis, NEOGEN Corporation. and Vetoquinol S.A., etc. Merck Animal Health (Merck & Co., Inc.), Boehringer Ingelheim International GmbH., Elanco Animal Health Incorporated are top 3 players and held % share in total in 2022.
Animal Health Surgery Drug can be divided into Opioids, Antibiotics, Anesthetics and Others, etc. Opioids is the mainstream product in the market, accounting for % share globally in 2022.
Animal Health Surgery Drug is widely used in various fields, such as Orthopedic Surgery, Dental Surgery, Sterilization Surgery and Others, etc. Orthopedic Surgery provides greatest supports to the Animal Health Surgery Drug industry development. In 2022, global % share of Animal Health Surgery Drug went into Orthopedic Surgery filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Animal Health Surgery Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Merck Animal Health (Merck & Co., Inc.)
Boehringer Ingelheim International GmbH.
Elanco Animal Health Incorporated
Virbac S.A.
Biogenesis Bago SA
Piramal Group
Zoetis
NEOGEN Corporation.
Vetoquinol S.A.
Ceva Santé Animale
Segment by Type
Opioids
Antibiotics
Anesthetics
Others
Orthopedic Surgery
Dental Surgery
Sterilization Surgery
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Animal Health Surgery Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Animal Health Surgery Drug introduction, etc. Animal Health Surgery Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Animal Health Surgery Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Animal Health Surgery Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Animal Health Surgery Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Orthopedic Surgery and Dental Surgery are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Animal Health Surgery Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Animal Health Surgery Drug key companies include Merck Animal Health (Merck & Co., Inc.), Boehringer Ingelheim International GmbH., Elanco Animal Health Incorporated, Virbac S.A., Biogenesis Bago SA, Piramal Group, Zoetis, NEOGEN Corporation. and Vetoquinol S.A., etc. Merck Animal Health (Merck & Co., Inc.), Boehringer Ingelheim International GmbH., Elanco Animal Health Incorporated are top 3 players and held % share in total in 2022.
Animal Health Surgery Drug can be divided into Opioids, Antibiotics, Anesthetics and Others, etc. Opioids is the mainstream product in the market, accounting for % share globally in 2022.
Animal Health Surgery Drug is widely used in various fields, such as Orthopedic Surgery, Dental Surgery, Sterilization Surgery and Others, etc. Orthopedic Surgery provides greatest supports to the Animal Health Surgery Drug industry development. In 2022, global % share of Animal Health Surgery Drug went into Orthopedic Surgery filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Animal Health Surgery Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Merck Animal Health (Merck & Co., Inc.)
Boehringer Ingelheim International GmbH.
Elanco Animal Health Incorporated
Virbac S.A.
Biogenesis Bago SA
Piramal Group
Zoetis
NEOGEN Corporation.
Vetoquinol S.A.
Ceva Santé Animale
Segment by Type
Opioids
Antibiotics
Anesthetics
Others
Segment by Application
Orthopedic Surgery
Dental Surgery
Sterilization Surgery
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Animal Health Surgery Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Animal Health Surgery Drug introduction, etc. Animal Health Surgery Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Animal Health Surgery Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.